Child and Family Research Institute, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
Eur J Pediatr. 2010 Jul;169(7):801-11. doi: 10.1007/s00431-009-1115-9. Epub 2009 Dec 15.
Schimke immunoosseous dysplasia (SIOD) is an autosomal recessive multisystem disorder characterized by prominent spondyloepiphyseal dysplasia, T cell deficiency, and focal segmental glomerulosclerosis. Biallelic mutations in swi/snf-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1 (SMARCAL1) are the only identified cause of SIOD, but approximately half of patients referred for molecular studies do not have detectable mutations in SMARCAL1. We hypothesized that skeletal features distinguish between those with or without SMARCAL1 mutations. Therefore, we analyzed the skeletal radiographs of 22 patients with and 11 without detectable SMARCAL1 mutations. We found that patients with SMARCAL1 mutations have a spondyloepiphyseal dysplasia (SED) essentially limited to the spine, pelvis, capital femoral epiphyses, and possibly the sella turcica, whereas the hands and other long bones are basically normal. Additionally, we found that several of the adolescent and young adult patients developed osteoporosis and coxarthrosis. Of the 11 patients without detectable SMARCAL1 mutations, seven had a SED indistinguishable from patients with SMARCAL1 mutations. We conclude therefore that SED is a feature of patients with SMARCAL1 mutations and that skeletal features do not distinguish who of those with SED have SMARCAL1 mutations.
希姆克免疫骨发育不良(SIOD)是一种常染色体隐性多系统疾病,其特征为显著的脊椎骨骺发育不良、T 细胞缺陷和局灶性节段性肾小球硬化。SWI/SNF 相关、基质相关、肌动蛋白依赖性染色质调节因子亚家族 A 样 1(SMARCAL1)的双等位基因突变是 SIOD 的唯一确定病因,但约一半接受分子研究的患者在 SMARCAL1 中未检测到可检测的突变。我们假设骨骼特征可区分有无 SMARCAL1 突变的患者。因此,我们分析了 22 例有和 11 例无可检测 SMARCAL1 突变的患者的骨骼 X 光片。我们发现,具有 SMARCAL1 突变的患者的脊椎骨骺发育不良(SED)基本上仅限于脊柱、骨盆、股骨头骨骺,可能还有蝶鞍,而手部和其他长骨基本上正常。此外,我们发现一些青少年和年轻成年患者发生骨质疏松症和髋关节炎。在 11 例无可检测 SMARCAL1 突变的患者中,有 7 例的 SED 与具有 SMARCAL1 突变的患者无法区分。因此,我们得出结论,SED 是 SMARCAL1 突变患者的特征,骨骼特征无法区分 SED 患者中谁具有 SMARCAL1 突变。